Clinical Trials

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Link : https://clinicaltrials.gov/ct2/show/NCT03967223
Status : CLOSED
Population : Synovial Sarcoma
Description : ACT in SS
PI : A. Razak
J. Noujaim
Centers Opened : PMH
HMR
Phase : II
IIST/Pharma : Pharma